Article | November 6, 2020

Covid-19 Impact On Bioprocessing: PART 3 Long-Term Changes Resulting From The Pandemic

By Eric Langer, Kamna Jhamb, and Ronald Rader

Laboratory scientist

We follow up our Parts 1 and 2 discussion of the impact of Covid-19 on bioprocessing, based on our recent White Paper that is also included in our research, (see www.bioplanassociates.com/17th). We interviewed major biopharmaceutical industry senior bioprocessing decision-makers, and bioprocessing suppliers in the US and Europe. The long-term effects on the biopharma and bioprocessing industry will likely impact emerging (smaller) biopharma companies and suppliers in similar ways.  For example, greater outsourcing will likely increase the number and size of projects for the larger Contract Manufacturing Organizations’. But it will also create opportunities for smaller, and niche CMOs.  

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: